Holdings of Atlas Venture Life Science Advisors, LLC
6 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 100 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 6 | 790M $ | 100.00 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Kymera Therapeutics Inc | 4,578,008 | 381.3M $ | |
| 2 | Dyne Therapeutics Inc | 9,130,465 | 165.5M $ | |
| 3 | Sionna Therapeutics Inc | 2,995,602 | 120.1M $ | |
| 4 | Disc Medicine Inc | 1,513,875 | 96.8M $ | |
| 5 | Q32 Bio Inc | 2,092,106 | 13.4M $ | |
| 6 | Korro Bio Inc | 1,137,149 | 12.9M $ |